Press Releases from Hermes Medical Solutions

Hermes Medical Solutions, a recognized global leader in molecular imaging and dosimetry software solutions, is proud to announce Hermia has been successfully included in the Australian Register of Therapeutic Goods (ARTG) by the Therapeutic Goods Administration (TGA). This milestone enables the company’s flagship vendor-neutral molecular imaging platform to expand access to Hermia for nuclear medicine, molecular imaging, and theranostics providers across Australia.

Hermes Medical Solutions, a global leader in molecular imaging and dosimetry software, announces the latest FDA cleared and CE-marked release of its flagship solution Hermia, featuring new capabilities designed to elevate precision, standardization, and efficiency in brain imaging.

Hermes Medical Solutions (HMS), global market leader in molecular imaging and dosimetry software solutions, receives 510(k) FDA Clearance for the new version of Hermia Voxel Dosimetry.

Hermes Medical Solutions (HMS), a global leader in molecular imaging and dosimetry software, announces the latest CE-marked release of its flagship platform, Hermia, featuring new capabilities designed to elevate precision, standardization, and efficiency in nuclear medicine.

Hermes Medical Solutions (HMS), a global leader in molecular imaging and dosimetry software solutions, proudly announces the latest updates within Hermia, including new CE marked functionalities*, designed to advance precision and efficiency in nuclear medicine imaging and dosimetry.

Hermes Medical Solutions is proud to announce its participation in the Foundation for the National Institutes of Health (FNIH) Biomarkers Consortium’s groundbreaking Precision Dosimetry Imaging Biomarker (PDIB) project. This ambitious international initiative seeks to transform radiopharmaceutical therapy (RPT) through improved dosimetry, leading to more effective and personalized cancer treatments.